BOSTON and SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small ...
New analysis examines RAP-219’s effect during the first month of treatment and consistency of efficacy over the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback